HomeAQSZF • OTCMKTS
add
Aequus Pharmaceuticals Inc
Previous close
$0.016
Year range
$0.0079 - $0.040
Market cap
3.32M CAD
Avg Volume
6.50K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
(CAD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 52.56K | -43.03% |
Operating expense | 645.50K | -15.97% |
Net income | -662.09K | 11.05% |
Net profit margin | -1.26K | -56.14% |
Earnings per share | — | — |
EBITDA | -609.08K | 14.60% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(CAD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 242.04K | 447.85% |
Total assets | 1.09M | 13.46% |
Total liabilities | 6.04M | 95.96% |
Total equity | -4.95M | — |
Shares outstanding | 132.63M | — |
Price to book | -0.41 | — |
Return on assets | -140.12% | — |
Return on capital | -204.27% | — |
Cash Flow
Net change in cash
(CAD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -662.09K | 11.05% |
Cash from operations | -521.70K | -95.40% |
Cash from investing | — | — |
Cash from financing | 593.55K | 867.32% |
Net change in cash | 71.85K | 134.94% |
Free cash flow | -289.15K | -5,624.67% |
About
Founded
2013
Headquarters
Website
Employees
12